- Home
- EVAX vs PPBT Comparison
EVAX vs PPBT Comparison
Compare EVAX & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- PPBT
- Stock Information
- Founded
- EVAX 2008
- PPBT 2010
- Country
- EVAX Denmark
- PPBT Israel
- Employees
- EVAX N/A
- PPBT N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- EVAX Health Care
- PPBT Health Care
- Exchange
- EVAX Nasdaq
- PPBT Nasdaq
- Market Cap
- EVAX 8.7M
- PPBT 8.7M
- IPO Year
- EVAX 2021
- PPBT N/A
- Fundamental
- Price
- EVAX $2.62
- PPBT $2.99
- Analyst Decision
- EVAX Strong Buy
- PPBT Strong Buy
- Analyst Count
- EVAX 3
- PPBT 2
- Target Price
- EVAX $33.33
- PPBT $126.50
- AVG Volume (30 Days)
- EVAX 6.9M
- PPBT 33.4K
- Earning Date
- EVAX 03-26-2025
- PPBT 03-04-2025
- Dividend Yield
- EVAX N/A
- PPBT N/A
- EPS Growth
- EVAX N/A
- PPBT N/A
- EPS
- EVAX N/A
- PPBT N/A
- Revenue
- EVAX $3,295,000.00
- PPBT N/A
- Revenue This Year
- EVAX $9,039.73
- PPBT N/A
- Revenue Next Year
- EVAX $1.47
- PPBT N/A
- P/E Ratio
- EVAX N/A
- PPBT N/A
- Revenue Growth
- EVAX N/A
- PPBT N/A
- 52 Week Low
- EVAX $2.22
- PPBT $2.00
- 52 Week High
- EVAX $22.50
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- EVAX 40.86
- PPBT 37.05
- Support Level
- EVAX $2.30
- PPBT $2.90
- Resistance Level
- EVAX $2.90
- PPBT $3.37
- Average True Range (ATR)
- EVAX 0.98
- PPBT 0.24
- MACD
- EVAX 0.02
- PPBT -0.02
- Stochastic Oscillator
- EVAX 5.28
- PPBT 15.69
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.